Source: Annual Congress 2007 - Cystic fibrosis: better diagnosis, improved progress, but long-term complications
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Conway, S. H. Chotirmall, P. Branagan, C. O‘Donohoe, N. G. McElvaney (Dublin, Ireland). Atopic cystic fibrosis patients: a poorer prognosis?. Eur Respir J 2007; 30: Suppl. 51, 2291

Member's Comments

No comment yet.

Related content which might interest you: Is age a predictor in prognosis of patients with idiopathic pulmonary fibrosis? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021 Year: 2022 Comorbidities of advanced diseases in patients with cystic fibrosis Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Characteristic of a subgroup of non cystic fibrosis bronchiectasis with concomitant asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Which score is better in association with exercise capacity and QoL in noncystic fibrosis bronchiectasis patients? FACED or BSI? Source: International Congress 2019 – Bronchiectasis Year: 2019 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Acute exacerbation in patients with bronchiectasis: What prognostic factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Prognosis of pulmonary sarcoidosis in young patients Source: Eur Respir J 2003; 22: Suppl. 45, 45s Year: 2003